Whittaker, S., Kirk, R., Hayward, R., Zambon, A., Viros, A., Cantarino, N., Affolter, A., Nourry, A., Niculescu-Duvaz, D., Springer, C., Marais, R. (2010) Gatekeeper Mutations Mediate Resistance to BRAF-Targeted Therapies. Science Translational Medicine, 2 (35). ISSN 1946-6234

Full text not available from this repository.

Item Type:	Article
Authors (ICR Faculty only):	Marais, Richard and Springer, Caroline and Niculescu-Duvaz, Dan
All Authors:	Whittaker, S., Kirk, R., Hayward, R., Zambon, A., Viros, A., Cantarino, N., Affolter, A., Nourry, A., Niculescu-Duvaz, D., Springer, C., Marais, R.
Additional Information:	ISI Document Delivery No.: 735OL Times Cited: 6 Cited Reference Count: 42 Whittaker, Steven Kirk, Ruth Hayward, Robert Zambon, Alfonso Viros, Amaya Cantarino, Neus Affolter, Annette Nourry, Arnaud Niculescu-Duvaz, Dan Springer, Caroline Marais, Richard Amer assoc advancement science Washington
Uncontrolled Keywords:	randomized discontinuation trial chronic myelogenous leukemia signal-regulated kinase renal-cell carcinoma b-raf cytogenetic responses phase-ii therapeutic target tyrosine kinases oncogenic braf
Research teams:	Closed research groups > Signal Transduction ICR divisions > Cancer Therapeutics > Gene & Oncogene Targeting
Depositing User:	Barry Jenkins
Date Deposited:	05 Apr 2011 10:21
Last Modified:	08 Nov 2012 15:58
URI:	http://publications.icr.ac.uk/id/eprint/10619

Actions (login required)

View Item